16 - ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment
Autor: | Purcell, J., Hickson, J., Tanlimco, S., Fox, M., Chao, D., Hsi, E., Sho, M., Powers, R., Foster-Duke, K., McGonigal, T., Uziel, T., Kumar, S., Samayoa, J., Longenecker, K., Lai, D., Hollenbaugh, D., Afar, D., Iyer, S., Morgan-Lappe, S., Gish, K. |
---|---|
Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S10-S10 |
Databáze: | ScienceDirect |
Externí odkaz: |